Program Schedule

HPV Screening and Vaccination: Controversies and Challenges

Friday, October 10, 2014: 2:00 PM-3:30 PM
Room: The Pennsylvania Convention Center: 120-ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe 2 indications of HPV testing in cervical cancer screening programs
  • summarize the public health impact of the 9-valent HPV vaccine
  • Recognize how clinicians can improve HPV vaccination rates in their practice settings
  • identify the benefits of the next generation HPV vaccine

Target Audience: Vaccinologists, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Lab personnel, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, HIV clinicians, Health care workers, Fellows, Epidemiologists, Clinicians

Tracks: Pediatric ID, Adult ID

Moderators:  Gail Bolan, MD, Centers for Disease Control and Prevention and Katherine Hsu, MD, MPH, Boston Univ Med Ctr

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits:

ACPE Number:


G. Bolan, None

K. Hsu, None

K. Ault, ACOG : Scientific Advisor, travel to meetings
Novavax: Investigator, Research grant and travel to meetings
Novartis: DSMB, travel to meetings

J. Bocchini Jr., None

A. Schuchat, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek